Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Ipsen

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Ipsen's 2013 oncology sales performance.

Ipsen S.A.

Botox strength bolsters Allergan ahead of AbbVie takeover

Botox strength bolsters Allergan ahead of AbbVie takeover Rival drugmaker Ipsen has market exclusivity for its rival botulinum toxin drug Dysport (abobotulinumtoxinA) in lower-limb spasticity caused by cerebral palsy following its 2016 FDA approval.

New hires at Bristol-Myers Squibb, Acceleron and FerGene

New hires at Bristol-Myers Squibb, Acceleron and FerGene pharmacoepidemiology. FerGene. FerGene has appointed David Meek (pictured left) as its new chief executive officer, who moves to the company from Ipsen. ... Most recently, he served as CEO of Ipsen, and he brings 30 years of industry experience to FerGene

Merck bulks up in cancer with $2.2bn Peloton buy

Merck bulks up in cancer with $2.2bn Peloton buy with Exelixis/Ipsen’s multikinase inhibitor Cabometyx (cabozantinib).

Ipsen buys rare disease group Clementia in $1.3bn deal

Ipsen buys rare disease group Clementia in $1.3bn deal Ipsen could enter a potentially lucrative market with palovarotene for both FOP and MO, for which there are no current treatments approved for these types of diseases. ... possible. “We anticipate a smooth transition of our operations into the Ipsen

Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team

Ipsen hires general manager, Laura Hamill joins Gilead and Orchard expands leadership team Asad Mohsin Ali has been appointed general manager of Ipsen UK and Ireland. ... Ali’s new role will see him lead Ipsen’s commercial presence in the UK and Ireland.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Origins Insights

Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...

Latest intelligence

Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
Serious about sustainability?
Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
How scientific storytelling can help Pharma cut through the noise
Rather than being afraid of storytelling, pharmaceutical firms should be embracing it. Because what scientific storytelling allows us to do is to communicate quickly and efficiently. It provides a shortcut...